Your article was successfully shared with the contacts you provided.
Lining up with California courts, the U.S. Court of Appeals for the Federal Circuit ruled Monday that the Food Drug & Cosmetic Act does not preempt private actors from using California law to crack down on unapproved drugs.
The ruling is a partial win for Allergan and its attorneys at Gibson, Dunn & Crutcher, who will now use it to prevent Athena Cosmetics from marketing in California a prostaglandin-based eyelash enhancer that has not been approved by the FDA.
This premium content is locked for The American Lawyer subscribers only.
Subscribe now to enjoy unlimited access to The American Lawyer content,
5 free articles* across the ALM Network every 30 days,
Exclusive access to other free ALM publications
And exclusive discounts on ALM events and publications.
*May exclude premium content Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to email@example.com to learn more.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.